HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
 Help
BNTC [NASD]
Benitec Biopharma Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-2.17 Insider Own9.92% Shs Outstand8.17M Perf Week-24.18%
Market Cap9.50M Forward P/E- EPS next Y-0.87 Insider Trans0.00% Shs Float7.36M Perf Month-6.58%
Income-17.10M PEG- EPS next Q-0.29 Inst Own24.70% Short Float0.13% Perf Quarter-60.39%
Sales0.03M P/S339.28 EPS this Y60.10% Inst Trans-0.39% Short Ratio0.00 Perf Half Y-65.74%
Book/sh0.92 P/B1.01 EPS next Y35.60% ROA-108.30% Target Price10.00 Perf Year-78.13%
Cash/sh- P/C- EPS next 5Y- ROE-127.40% 52W Range0.74 - 4.78 Perf YTD-64.69%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-80.65% Beta1.41
Dividend %- Quick Ratio4.60 Sales past 5Y- Gross Margin- 52W Low25.00% ATR0.23
Employees14 Current Ratio4.60 Sales Q/Q2400.00% Oper. Margin- RSI (14)44.12 Volatility32.07% 21.49%
OptionableYes Debt/Eq0.00 EPS Q/Q51.30% Profit Margin- Rel Volume0.28 Prev Close1.16
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume2.16M Price0.93
Recom2.00 SMA20-7.80% SMA50-22.59% SMA200-62.36% Volume611,014 Change-20.26%
Oct-05-20Downgrade Ladenburg Thalmann Buy → Neutral
Apr-20-20Initiated Ladenburg Thalmann Buy $14
Feb-26-16Downgrade Maxim Group Buy → Hold
Dec-31-15Reiterated Maxim Group Buy $23 → $14
Sep-16-15Reiterated Maxim Group Buy $4 → $23
May-16-22 08:15AM  
Benitec Biopharma Releases Q3 2022 Financial Results
GlobeNewswire -8.79%
Feb-14-22 08:00AM  
Benitec Biopharma Discloses Q2 2022 Financial Results
PR Newswire
Jan-18-22 12:53PM  
/C O R R E C T I O N from Source -- Norra Metals Corp./
CNW Group -6.64%
Jan-17-22 09:30AM  
Norra Metals Announces Private Placement Financing
CNW Group
Nov-27-21 06:54AM  
We're Keeping An Eye On Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate
Simply Wall St.
Nov-15-21 08:00AM  
Benitec Biopharma Discloses Q1 2022 Financial Results
PR Newswire
Sep-20-21 08:00AM  
Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results
PR Newswire -7.86%
Sep-13-21 03:58PM  
Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference
PR Newswire
Sep-08-21 08:10AM  
Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022
PR Newswire
08:05AM  
Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals
PR Newswire
08:00AM  
Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022
PR Newswire
May-31-21 01:54AM  
Is Benitec Biopharma (NASDAQ:BNTC) In A Good Position To Invest In Growth?
Simply Wall St.
Apr-27-21 09:55PM  
Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million
PR Newswire
04:44PM  
Benitec Biopharma Announces $7.5 Million Bought Deal Offering of Common Stock
PR Newswire
Mar-23-21 12:18PM  
5 Top Stock Gainers for Tuesday: Dolphin Entertainment, Benitec
TheStreet.com +190.28%
07:24AM  
Tuesdays Pre-Market: Heres What You Need To Know Before The Market Opens
SmarterAnalyst
07:09AM  
Benitec Shares Skyrocket as Morgan Stanley Takes Stake
TheStreet.com
Feb-24-21 09:26AM  
Benitec Biopharma's Gene Therapy For Rare Muscle Disorder Shows Encouraging Action In Animal Studies
Benzinga +5.60%
08:29AM  
Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study
PR Newswire
Dec-07-20 02:33PM  
Benitec Biopharma Announces 2020 Annual Stockholder Meeting
PR Newswire
Dec-02-20 12:06AM  
A Quick Analysis On Benitec Biopharma's (NASDAQ:BNTC) CEO Compensation
Simply Wall St.
Oct-06-20 04:05PM  
Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
PR Newswire
Oct-02-20 09:05AM  
Benitec Biopharma Announces Pricing of $10.0 Million Public Offering
PR Newswire -36.74%
Sep-23-20 04:54PM  
Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results
PR Newswire
Sep-01-20 08:15AM  
Benitec Biopharma to present at H.C. Wainwright's 22nd Annual Global Investment Conference
PR Newswire
Jul-08-20 08:00AM  
Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study
PR Newswire
Apr-20-20 06:49AM  
Should You Be Concerned About Benitec Biopharma Limited's (NASDAQ:BNTC) Historical Volatility?
Simply Wall St. +124.78%
Apr-15-20 08:52AM  
Benitec Biopharma Announces the Completion of Redomiciliation to the United States
PR Newswire -10.75%
Apr-14-20 09:28PM  
Benitec Biopharma Appoints Edward Smith to the Board of Directors
PR Newswire -10.31%
Mar-30-20 10:09AM  
Benitec Announces Supreme Court of Queensland Approval for Redomicile
PR Newswire
Mar-26-20 09:44AM  
Benitec Announces Results of Scheme Meeting
PR Newswire +7.60%
Feb-27-20 06:18PM  
Is Benitec Biopharma (ASX:BLT) In A Good Position To Deliver On Growth Plans?
Simply Wall St.
Jan-31-20 08:08AM  
Appendix 4C: Quarterly Cash Flow Report
PR Newswire -6.73%
Nov-27-19 08:00AM  
ASX/NASDAQ ANNOUNCEMENT: Re-domiciliation to the United States
PR Newswire -10.17%
Nov-17-19 07:02PM  
Some Benitec Biopharma (ASX:BLT) Shareholders Have Taken A Painful 93% Share Price Drop
Simply Wall St.
Nov-15-19 07:00AM  
Public consultation launched on global tailings dam standards
Reuters
Oct-31-19 08:30AM  
Appendix 4C: Quarterly Cash Flow Report
PR Newswire
Sep-30-19 09:24AM  
Benitec Biopharma Limited Announces US$2.25 Million Registered Direct Offering
PR Newswire -15.24%
Sep-19-19 09:15AM  
Benitec Biopharma to present at Ladenburg Thalmann 2019 Healthcare Conference
PR Newswire
Sep-16-19 08:00AM  
Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program
PR Newswire
Sep-15-19 09:49PM  
Does Market Volatility Impact Benitec Biopharma Limited's (ASX:BLT) Share Price?
Simply Wall St.
Jul-31-19 08:30AM  
ASX/NASDAQ ANNOUNCEMENT Appendix 4C: Quarterly Cash Flow Report
PR Newswire
Jul-11-19 11:34PM  
Could The Benitec Biopharma Limited (ASX:BLT) Ownership Structure Tell Us Something Useful?
Simply Wall St.
Jun-06-19 08:09AM  
Update on Oculopharyngeal Muscular Dystrophy Program
PR Newswire
May-08-19 08:01PM  
Should Benitec Biopharma Limited (ASX:BLT) Be Your Next Stock Pick?
Simply Wall St.
Mar-06-19 09:52PM  
Introducing Benitec Biopharma, The Stock That Tanked 92%
Simply Wall St.
Jan-29-19 09:46PM  
Have Insiders Been Buying Benitec Biopharma Limited (ASX:BLT) Shares This Year?
Simply Wall St.
Dec-21-18 10:10AM  
Benitec Provides Update on BB-401 Cancer Treatment Program
PR Newswire
Nov-23-18 12:01AM  
Is Benitec Biopharma Limiteds (ASX:BLT) Balance Sheet A Threat To Its Future?
Simply Wall St.
Nov-15-18 07:35AM  
Detailed Research: Economic Perspectives on Knight-Swift Transportation, Benitec Biopharma, Eastern, Kiniksa Pharmaceuticals, Qualstar, and Nomura Holdings Inc ADR What Drives Growth in Today's Competitive Landscape
GlobeNewswire
Sep-19-18 08:00AM  
Benitec Biopharma Announces the Appointment of Gregory R. Reyes, M.D., Ph.D. as Senior Scientific Advisor
PR Newswire
Jul-14-18 02:02PM  
3 Biotech Stocks That Soared This Week: Are They Buys?
Motley Fool
Jul-10-18 05:15PM  
Axovant, Benitec Gain on Licensing Deal for Gene Therapy
Zacks
08:10AM  
Today's Research Reports on Stocks to Watch: Benitec Biopharma and Pfizer
ACCESSWIRE
07:30AM  
New Catalysts Could Send This $3 Medical Device Stock to $9
ACCESSWIRE
Jul-09-18 11:04AM  
Axovant, Benetic Jump on Agreement to Develop Gene Therapy for MD
TheStreet.com
Jul-08-18 08:59PM  
Benitec Announces Global Licensing Agreement for BB-301 for Treatment of Oculopharyngeal Muscular Dystrophy and Broad Platform Collaboration with Axovant
PR Newswire
May-31-18 08:00AM  
Benitec Biopharma reports financial results for the 2018 fiscal third quarter and provides operational update
PR Newswire
May-15-18 08:00AM  
Benitec to present OPMD data at the American Society of Gene and Cell Therapy Meeting
PR Newswire
May-03-18 08:00AM  
Benitec to Host Investor Webinar on the Company's Oculopharyngeal Muscular Dystrophy (OPMD) Program
PR Newswire
Apr-24-18 08:00AM  
ASX/NASDAQ Announcement
PR Newswire
Mar-05-18 08:00AM  
Benitec Biopharma Launches its Phase 2 Oncology Study in Australia
PR Newswire
Feb-22-18 08:30AM  
Benitec Biopharma reports financial results for the 2018 fiscal second quarter and provides operational update
PR Newswire
Jan-23-18 04:17PM  
Federal R&D Tax Credit Received
PR Newswire
Jan-16-18 08:00AM  
Benitec receives U.S. Orphan Drug Designation for BB-301, its ddRNAi therapeutic for the treatment of oculopharyngeal muscular dystrophy
PR Newswire
Nov-27-17 09:30AM  
Alkermes Jumps on License Deal With Biogen -- Biotech Movers
TheStreet.com
08:00AM  
Benitec Biopharma provides update on OPMD orphan disease program
PR Newswire
Oct-18-17 07:45AM  
U.S. patent granted for Benitec hepatitis B program
PR Newswire
Sep-05-17 02:54PM  
Benitec Biopharma Ltd. :BNTC-US: Earnings Analysis: For the six months ended June 30, 2017 : September 5, 2017
Capital Cube
Sep-01-17 04:00PM  
Benitec Biopharma Ltd. :BNTC-US: Earnings Analysis: 2017 By the Numbers : September 1, 2017
Capital Cube
Aug-08-17 08:30AM  
Benitec Biopharma advances OPMD orphan disease program
PR Newswire
Apr-05-17 07:30AM  
Today's Research Reports on Biotech Stocks to Watch: Benitec Biopharma and Paratek Pharmaceuticals
Accesswire
07:30AM  
Today's Research Reports on Biotech Stocks to Watch: Benitec Biopharma and Paratek Pharmaceuticals
Apr-04-17 04:40PM  
Rising Biotechs: Paratek Among Stocks Surging On Trial Results
Investor's Business Daily
04:40PM  
Rising Biotechs: Paratek Among Stocks Surging On Trial Results
11:54AM  
Here's Why Benitec Biopharma Stock Soared 79.7% Higher This Morning
Motley Fool
08:00AM  
Key pre-clinical data on oculopharyngeal muscular dystrophy (OPMD) published in Nature Communications
PR Newswire
08:00AM  
Key pre-clinical data on oculopharyngeal muscular dystrophy (OPMD) published in Nature Communications
Mar-27-17 09:30AM  
Increased Volume Spurs Stock Prices of Benitec Biopharma, Regulus Therapeutics
Accesswire
Mar-13-17 06:00AM  
Benitec Biopharma completes second tranche placement to Nant Capital to raise A$5.45 million
PR Newswire
Feb-16-17 08:00AM  
Benitec Biopharma to present expanded data set from pivotal data in hepatitis B virus (HBV) in vivo model at International Liver Meeting in Shanghai, China
PR Newswire
Feb-03-17 09:45AM  
M&A Activity Could Kick Start Biotech Industry's Recovery in 2017: Today's Report on Benitec and Protalix
Accesswire
Feb-02-17 12:05PM  
Why Benitec More Than Doubled
24/7 Wall St.
12:05PM  
Why Benitec More Than Doubled
07:00AM  
Benitec Biopharma makes significant progress in ocular program
PR Newswire
Jan-30-17 08:00AM  
Benitec initiates development work on head and neck cancer programs after executing Collaboration Agreement with Nant Capital
PR Newswire
Jan-18-17 09:30AM  
Biotech Industry Outperforming Markets in 2017: Latest Reports on Benitec Biopharma and Tandem Diabetes Care
Accesswire
08:26AM  
Benitec Stock Up on Orphan Drug Status for BB-301 in EU
Zacks
08:15AM  
Blog Coverage Benitec Biopharma Secures Orphan Drug Designation for its Product Treating Patients with Oculopharyngeal Muscular Dystrophy
Accesswire
Jan-17-17 11:05AM  
Tuesdays Top Biopharma Movers
24/7 Wall St.
05:00AM  
Benitec Receives Orphan Drug Designation in the European Union for BB-301, a ddRNAi Therapeutic in Development for the Treatment of Oculopharyngeal Muscular Dystrophy
PR Newswire
Dec-23-16 06:00AM  
Benitec in-licenses clinical program for head and neck cancer from NantWorks
PR Newswire
Dec-20-16 07:00AM  
Benitec releases pivotal data in an in vivo hepatitis B model
PR Newswire
Oct-24-16 07:10PM  
Benitec initiates a strategic engagement with NantVentures
Other
Sep-23-16 11:34AM  
Benitec Biopharma Ltd. :BNTC-US: Earnings Analysis: 2016 By the Numbers : September 23, 2016
Aug-10-16 05:00AM  
Benitec announces restructuring of Senior Executive team
PR Newswire
May-24-16 04:45AM  
Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016
PR Newswire
May-17-16 05:00AM  
Benitec Biopharma to Host Corporate Update Conference Call
PR Newswire
Apr-25-16 08:30AM  
Benitec to present at the ASGCT 2016 Annual Meeting
PR Newswire
Mar-08-16 08:16AM  
Benitec's Hepatitis B Therapy Reduces HBV DNA by 98.5% In Vivo
PR Newswire
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Oliveira Steven Michael10% OwnerDec 09Buy3.0410,55332,1261,000,000Dec 09 04:55 PM
Oliveira Steven Michael10% OwnerNov 29Buy3.1837,947120,687989,447Dec 09 04:55 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do Not Sell My Data • Privacy Settings
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2022 FINVIZ.com. All Rights Reserved.